CELL CYCLE

投稿咨询

官方网站：http://www.tandfonline.com/loi/kccy20#.V4iIR0z9cSQ

投稿网址：http://www.tandfonline.com/action/authorSubmission?journalCode=kccy20&page=instructions#.V4iIU0z9cSQ

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1538-4101%5BISSN%5D

《细胞周期》是一本双周同行评审的杂志，内容涉及细胞生物学各个领域的重点研究。细胞周期涵盖了从酵母到人类的所有话题，从DNA到功能，从发育到衰老，从干细胞到细胞衰老，从新陈代谢到细胞死亡，从癌症到神经生物学，从分子生物学到治疗学。我们的目标是快速发表杰出的研究成果。细胞周期有一个著名的编辑委员会，其中包括3位诺贝尔奖得主和其他杰出的科学家。《细胞周期》创刊于2002年，由其创始人兼主编米哈伊尔v布拉戈斯科龙尼(Mikhail V. Blagosklonny)创办，目前是该领域最大的期刊之一。曾经是双月刊，现在是双周刊(2015年PubMed上有7000篇论文)。手稿类别包括:研究论文/报告观点/评论邀请后续的重要文章发表在细胞周期和其他地方:额外的意见，功能，新闻和意见Cell Cycle提供在线稿件提交和由独立的匿名专家评审专家评审，以及灵活的开放获取政策。该期刊由PubMed/Medline、汤森路透和Scopus编制索引。它有印刷和在线两种格式。Cell Cycle将根据主编的决定，考虑以前提交给其他高影响力期刊的审稿人报告，以便加快审稿速度。优先级高的论文将被同行评审并尽快发表。

Cell Cycle is a bi-weekly peer-reviewed journal of high priority research from all areas of cell biology. Cell Cycle covers all topics from yeast to man, from DNA to function, from development to aging, from stem cells to cell senescence, from metabolism to cell death, from cancer to neurobiology, from molecular biology to therapeutics. Our goal is fast publication of outstanding research. Cell Cycle has a prominent Editorial Board, which includes 3 Nobel Prize winners and other outstanding scientists. Launched in 2002 by its founding Editor and Editor-in-Chief, Mikhail V. Blagosklonny, Cell Cycle is now one of the largest journals in the field. Once bi-monthly, it is now bi-weekly (7000 papers on PubMed in 2015.) Categories of manuscripts include:Research papers/ReportsPerspectives/ReviewsInvited follow-ups to important articles published in Cell Cycle and elsewhere: Extra Views, Features, News and ViewsCell Cycle offers online manuscript submission and peer-review by independent, anonymous expert referees, as well as a flexible open access policy. The journal is indexed by PubMed/Medline, Thomson Reuters, and Scopus. It is available both in the print and online formats. Cell Cycle will, at the discretion of the Chief Editor, consider reviewer reports from previous submission to other high-impact journals for accelerated review. High-priority papers will be peer-reviewed and published as soon as possible.